Post-approval studies (Phase 4)Study completedNCT01491087
What this trial is testing
Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China
Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi Pasteur, a Sanofi Company 900